Supervised Exercise-based Rehabilitation for People With Intermittent Claudication in Denmark
Launched by SLAGELSE HOSPITAL · Mar 1, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a supervised exercise program combined with smoking cessation support for adults with intermittent claudication, a condition that causes leg pain when walking due to poor blood flow. The goal is to help participants improve their walking ability and overall health through structured exercise, which involves walking on a treadmill three times a week for 12 weeks. The program will also assist smokers in quitting, as this can improve their condition.
To join the trial, participants should be adults aged 65 to 74 who experience leg pain when walking that goes away when resting. They must have a certain level of blood flow in their legs, measured by specific tests. However, individuals with certain medical conditions that prevent them from safely participating will not be included. Throughout the program, the researchers will monitor progress and gather feedback to ensure the intervention is effective. Participants will have the opportunity to improve their health while contributing to important research on this condition.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Relevant symptoms of intermittent claudication; leg pain when walking due to arteriosclerosis and relieve of symptoms during rest.
- • Distal blood pressure with an ankle-brachial index (ABI) \> 50 mmHg for non-diabetics or toe brachial index (TBI) \> 40 mmHg for diabetics.
- Exclusion criteria:
- • • Evaluated by a vascular surgeon: patients with contraindications e.g. medical issues or comorbidity that enables a participation in SET are not referred.
About Slagelse Hospital
Slagelse Hospital is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. As a prominent clinical trial sponsor, the hospital focuses on innovative studies aimed at improving patient outcomes and enhancing treatment methodologies across various medical disciplines. With a commitment to ethical standards and patient safety, Slagelse Hospital collaborates with multidisciplinary teams of healthcare professionals and researchers to explore new therapeutic approaches and contribute to the advancement of medical knowledge. Through its robust clinical trial programs, the hospital strives to address pressing health challenges and foster a culture of scientific inquiry and excellence in patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Slagelse, , Denmark
Patients applied
Trial Officials
Helle Bøgard
Principal Investigator
Slagelse Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported